Host: |
Rabbit |
Applications: |
IHC/IF/WB/ELISA |
Reactivity: |
Human/Rat/Mouse |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-NK-tumor recognition protein (784-833) is suitable for use in Immunohistochemistry, Immunofluorescence, Western Blot and ELISA research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
Concentration: |
1 mg/mL |
Dilution Range: |
WB 1:500-2000IHC 1:100-1:300IF 1:200-1:1000ELISA 1:40000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
NKTR |
Gene ID: |
4820 |
Uniprot ID: |
NKTR_HUMAN |
Immunogen Region: |
784-833 |
Specificity: |
NK-TR Polyclonal Antibody detects endogenous levels of NK-TR protein. |
Immunogen: |
The antiserum was produced against synthesized peptide derived from human NKTR. AA range:784-833 |
Function | PPIase that catalyzes the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and may therefore assist protein folding. Component of a putative tumor-recognition complex involved in the function of NK cells. |
Protein Name | Nk-Tumor Recognition ProteinNk-Tr ProteinNatural-Killer Cells Cyclophilin-Related ProteinPeptidyl-Prolyl Cis-Trans Isomerase NktrPpiaseRotamase |
Cellular Localisation | Cell Membrane |
Alternative Antibody Names | Anti-Nk-Tumor Recognition Protein antibodyAnti-Nk-Tr Protein antibodyAnti-Natural-Killer Cells Cyclophilin-Related Protein antibodyAnti-Peptidyl-Prolyl Cis-Trans Isomerase Nktr antibodyAnti-Ppiase antibodyAnti-Rotamase antibodyAnti-NKTR antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance